Cleared Traditional

K132105 - PERCLOT TOPICAL (FDA 510(k) Clearance)

Apr 2014
Decision
269d
Days
-
Risk

K132105 is an FDA 510(k) clearance for the PERCLOT TOPICAL. Classified as Hemostatic Wound Dressing Without Thrombin Or Other Biologics (product code QSY).

Submitted by Cryolife, Inc. (Kennesaw, US). The FDA issued a Cleared decision on April 3, 2014 after a review of 269 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

Submission Details

510(k) Number K132105 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 2013
Decision Date April 03, 2014
Days to Decision 269 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
137d slower than avg
Panel avg: 132d · This submission: 269d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device Class -
Definition To Temporarily Control Bleeding And Cover External Wounds.

Regulatory Peers - QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics

Devices cleared under the same product code (QSY) and FDA review panel - the closest regulatory comparables to K132105.
Ganymede 2cm diameter (FG100300)
K251700 · Speciality Fibres and Materials Limited · Feb 2026
MFUSE (MS001)
K250319 · Machina Medical, Inc. · Dec 2025
TRAUMAGEL® 2.0 Hemostatic Gel
K253609 · Cresilon, Inc. · Dec 2025
Celox Rapid X-Ray Gauze
K230589 · Medtrade Products , Ltd. · Nov 2023